Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis

摘要

Psoriasis is a common inflammatory disorder of the skin and other organs. We have determined that mutations in CARD14, encoding a nuclear factor of kappa light chain enhancer in B cells (NF-kB) activator within skin epidermis, account for PSORS2. Here, we describe fifteen additional rare missense variants in CARD14, their distribution in seven psoriasis cohorts (6,000 cases and 4,000 controls), and their effects on NF-kB activation and the transcriptome of keratinocytes. There were more CARD14 rare variants in cases than in controls (burden test p value = 0.0015). Some variants were only seen in a single case, and these included putative pathogenic mutations (c.424GA [p.Glu142Lys] and c.425AG [p.Glu142Gly]) and the generalized-pustular- psoriasis mutation, c.413AC (p.Glu138Ala); these three mutations lie within the coiled-coil domain of CARD14. The c.349GA (p.Gly117Ser) familial-psoriasis mutation was present at a frequency of 0.0005 in cases of European ancestry. CARD14 variants led to a range of NF-kB activities; in particular, putative pathogenic variants led to levels 2.5× higher than did wild-type CARD14. Two variants (c.511CA [p.His171Asn] and c.536GA [p.Arg179His]) required stimulation with tumor necrosis factor alpha (TNF-α) to achieve significant increases in NF-kB levels. Transcriptome profiling of wild-type and variant CARD14 transfectants in keratinocytes differentiated probably pathogenic mutations from neutral variants such as polymorphisms. Over 20 CARD14 polymorphisms were also genotyped, and meta-analysis revealed an association between psoriasis and rs11652075 (c.2458CT [p.Arg820Trp]; p value = 2.1 × 10 -6). In the two largest psoriasis cohorts, evidence for association increased when rs11652075 was conditioned on HLA-Cw 0602 (PSORS1). These studies contribute to our understanding of the genetic basis of psoriasis and illustrate the challenges faced in identifying pathogenic variants in common disease.